Lisses, France, October 11, 2022 – Sebia, a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and ...
Sebia is the world's leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing. Its systems analyze proteins in order to ...
LISSES, France, June 30, 2021 /PRNewswire/ -- Sebia, a leading provider of clinical protein electrophoresis equipment and reagents for diabetes and oncology detection, today announced the acquisition ...
Lisses-headquartered Sebia, a global specialty diagnostic company providing innovative solutions for screening and diagnostics in oncology, metabolic diseases, genetic disorders and autoimmune ...
Expanding its offering for Multiple Myeloma and AL Amyloidosis Testing LISSES, France — Sebia, a global specialty diagnostic company providing innovative solutions for screening and diagnostics in ...
The next generation instrument for screening hemoglobin disorders in newborns. LISSES, France–(BUSINESS WIRE)–#NBS—Sebia, a global specialty diagnostic company providing innovative solutions for ...
(Bloomberg) — Blackstone, Warburg Pincus and Nordic Capital are among private equity bidders looking to invest in French diagnostics provider Sebia, which could be valued at around €5 billion, ...
The strategic acquisition reinforces Sebia's global leadership in specialty diagnostics LISSES, France, June 30, 2021 /PRNewswire/ --Sebia, a leading provider of clinical protein electrophoresis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback